
MEP Group
About MEP Group
MEP Group is an Industrial Goods & Manufacturing company, and was acquired by Wise Equity in January 2024. Ready-to-administer injectable pharmaceuticals are developed, produced, and distributed. The company was acqui-hired. Its focus areas include Industrial Goods and Manufacturing and Manufacturing Services.
Company details
Injectable pharmaceuticals are manufactured in the healthcare sector, with a focus on ready-to-administer formats. High-quality medications, including naloxone hydrochloride and sodium heparin, are produced in pre-filled syringes to support efficient administration. Development and distribution processes are conducted under strict regulatory compliance and quality controls. Operations emphasize precision in formulation and packaging to meet clinical needs.
- Stage Acquired
- SectorsIndustrial Goods & Manufacturing
- Website mepgroup.com
- Social LinkedIn X
- Acquired by Legris (Jun 2019)
- InvestorsLegris
& 1 more
- Acquired by
Investors in MEP Group
MEP Group has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Legris and Wise Equity.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity funds are managed for Italian SMEs. | 2000 | wisesgr.com | Milan, Italy | |
Manufacturer of twin-screw extrusion and power supply systems | 1986 | legris-industries.com | Brussels, Belgium |
Investor details for MEP Group
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of MEP Group
2 dated milestones of MEP Group across 5 years, from founding to its latest funding, stage changes and deals.
- Exit Acquired by Legris.
- Exit Acquired by Wise Equity.
Web traffic of MEP Group
The website of MEP Group (mepgroup.com) receives about 6.4K visits a month.
- Monthly visits6.4K
▼ 28.3% vs previous month
Websites whose visitors overlap most with MEP Group. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| mepsaws.it | 100% | 4.8K | #3,529,881 | View details | |
paris-en.intermatconstruction.com | paris-en.intermatconstruction.com | 61% | β | ||
mep.com | mep.com | 22% | β |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about MEP Group
Injectable pharmaceuticals are manufactured in the healthcare sector, with a focus on ready-to-administer formats. High-quality medications, including naloxone hydrochloride and sodium heparin, are produced in pre-filled syringes to support efficient administration. Development and distribution processes are conducted under strict regulatory compliance and quality controls. Operations emphasize precision in formulation and packaging to meet clinical needs.
MEP Group has 2 investors. Key investors include Legris, and Wise Equity.
Yes. MEP Group was acquired by Legris in June 2019.